• Eczema
  • COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Our health is not sufficiently protected from air pollution, says the EU Court of auditors
Every year, more than 400,000 premature deaths in the EU are caused by air pollution, resulting in significant human and economic costs. A new report from the European Court of Auditors published in ...

Read more

Patient priorities at the International Congress of Aerobiology
From September 3-7, EFA Director of Operations and Projects travelled to Parma to speak at the International Congress of Aerobiology about the problems that respiratory allergy poses to Europeans. He  ...

Read more

Subscribe to our free webinars to increase national patient capacity
The time for EFA’s yearly capacity building training has arrived! Do you have what it takes to be advocate for the patient needs but you are missing impact?  Do you feel you can improve this or t ...

Read more

EFA and EAACI sign memorandum of understanding
EFA has signed a memorandum of understanding with the European Academy of Allergy and Clinical Immunology (EAACI), a longstanding partner of EFA. This memorandum of understanding will lay the groundwo ...

Read more

Swedish patients launch an online recipe bank
EFA Member the Swedish Asthma and Allergy Association has launched the recipe bank, Receptbanken, where people can search for individual ingredients that they want to exclude or include. The purpose o ...

Read more

The new AFPRAL magazine is published
EFA Member the French Association for Allergy Prevention is pleased to announce the launch of the new Allergy magazine, Le Mag. The whole AFPRAL team has conceived it as a communication and informatio ...

Read more

SAVE THE DATE! The European Parliament Interest Group’s event on the barriers to research in chronic NCDs in Europe
Next 9th October 2018, the European Parliament Interest Group on Allergy and Asthma, is organising an event entitled “How to overcome the barriers to research in chronic NCDs in Europe? The case of al ...

Read more

Should the EU revise the EU Ambient Air Quality Directives? Patients say YES!
The European Commission launched in May-July a process to gather information on the impact and added value of the EU Ambient Air Quality Directives from stakeholders. It is what has been fancily calle ...

Read more

The 7th Environment Action Programme evaluated by allergy and respiratory patients
The European Commission launched a public consultation to evaluate the 7th Environment Action Programme (7th EAP), which is the strategic document that guides EU policy to reduce pollution in the air, ...

Read more

Is the role of patients neglected in the prevention of Chronic Respiratory Disease? Our presentation at GARD
EFA Board Member, Hubert Nettel, had the honour to present in the opening of the 12th Global Alliance against Chronic Respiratory Diseases (GARD) General Meeting entitled “The Natural Step to Respirat ...

Read more

HTA proposal approved by the European Parliament health committee leaves out some patients expectations
The proposal for a regulation on Health Technology Assessment (HTA) has been high on the agenda of the European Parliament during the last months. The Committee on the Environment, Public Health and F ...

Read more

EU-UK patient group meets the European Commission to discuss Brexit
In July, our Director Susanna Palkonen chaired a meeting on behalf of the European Patients’ Forum and coordinated by the Association of Medical Research Charities UK (AMRC) to meet the Brexit taskfor ...

Read more

New President for the food allergy patients in France
AFPRAL, the French Association for the Prevention of Allergies, has a new elected president, Pascale Couratier, replacing exiting President Véronique Olivier. Pascale has been working for AFPRAL for m ...

Read more

EUROPEAN REPORT: Itching for life - Quality of Life and costs for people with severe atopic eczema in Europe
EFA's 2018 European report Itching for Life: Quality of Life and costs for people living with severe atopic eczema in Europe uncovers the reality of atopic eczema, a chronic inflammatory skin dis ...

Read more

PRESS RELEASE: 1st European Atopic Eczema Awareness Day
On the 1st European Atopic Eczema Awareness Day New patients report uncovers the reality of severe atopic eczema in Europe [Press release avaiable in 9 European languages below] PARIS, 14/09/201 ...

Read more

Health Technology Assessment (HTA) in the spotlight in the European Parliament
In July, the European Parliament committee for Internal Market and Consumer Protection (IMCO) adopted its opinion on a report done by the Environment, Public Health and Food Safety Committee (ENVI) ...

Read more

We want a future cooperation on HTA with patients at the center
On the 5thof June, we attended “What future for EU cooperation on HTA?” organised by the European Parliament Interest Group on Access to HealthCare, in cooperation with the Patient Access Partnership  ...

Read more

ENSP International Conference on Tobacco Control: new tobacco products, new evidence, need for stricter regulations
On the 14-16thJune, EFA Isabel Proaño participated at the European Network for Smoking and Tobacco Prevention (ENSP) International Conference on Tobacco Control hosted in Madrid. As partners of the  ...

Read more

IMI and its 10 years of medical innovation, the example of U-BIOPRED
On June 27th we were 400 participants to celebrate an outstanding achievement on medical research. In the last ten years, the Innovative Medicine Initiative has done more than 100 European projects an ...

Read more

AEPNAA Summer Camp 2018 for children with food and latex allergies
From June the 23rd to July the 1st , AEPNAA organised  their annual Summer Camp, aiming towards children with food and latex allergies. During this week, children between 6 and 16 years ...

Read more